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Abstract
Background: Gene targeting (GT) provides a powerful tool for the generation of precise genetic alterations in embryonic
stem (ES) cells to elucidate gene function and create animal models for human diseases. This technology has, however,
been limited to mouse and rat. We have previously established ES cell lines and procedures for gene transfer and selection
for homologous recombination (HR) events in the fish medaka (Oryzias latipes).
Methodology and Principal Findings: Here we report HR-mediated GT in this organism. We designed a GT vector to disrupt
the tumor suppressor gene p53 (also known as tp53). We show that all the three medaka ES cell lines, MES1,MES3, are
highly proficient for HR, as they produced detectable HR without drug selection. Furthermore, the positive-negative
selection (PNS) procedure enhanced HR by ,12 folds. Out of 39 PNS-resistant colonies analyzed, 19 (48.7%) were positive
for GT by PCR genotyping. When 11 of the PCR-positive colonies were further analyzed, 6 (54.5%) were found to be bona
fide homologous recombinants by Southern blot analysis, sequencing and fluorescent in situ hybridization. This produces
a high efficiency of up to 26.6% for p53 GT under PNS conditions. We show that p53 disruption and long-term propagation
under drug selection conditions do not compromise the pluripotency, as p53-targeted ES cells retained stable growth,
undifferentiated phenotype, pluripotency gene expression profile and differentiation potential in vitro and in vivo.
Conclusions: Our results demonstrate that medaka ES cells are proficient for HR-mediated GT, offering a first model
organism of lower vertebrates towards the development of full ES cell-based GT technology.
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Introduction
Gene targeting (GT) in mouse embryonic stem (ES) cells has
been used as a powerful tool for analyzing gene function [1]. In
this approach, precise alterations are introduced into ES cells at
particular loci by gene replacement, and targeted ES cells are
introduced into early embryos for the formation of chimeras in
which transplanted ES cells contribute to many lineages including
the germline. Crossing of germline chimeras lead to the pro-
duction of animals that are heterozygous or homozygous for the
targeted locus. GT in ES cells has been reported also in human [2]
and rat [3]. Because of the availability of pluripotent ES cell lines
and the possibility of germline chimera formation, however, the
production of knockout animals from targeted ES cells has long
been limited to mouse [4] before its recent expansion into rat [5].
The effort towards GT has steadily been attempted in non-
mammalian species such as lower vertebrates, in particular
zebrafish and medaka (Oryzias latipes). In zebrafish, Collodi and
his colleagues have reported targeted insertion of a plasmid by HR
in zebrafish ES cell cultures [6]. More importantly, zebrafish with
targeted gene mutations have been generated by using zinc finger
nucleases (ZFNs) [7,8] and transcription activator-like effector
nucleases (TALENs) [9].
We and others use the medaka (Oryzias latipes) as a model
organism to develop the GT technology. Like zebrafish, this fish is
an excellent model for analyzing vertebrate development [10]. In
this organism, we have obtained various stem cell lines of diploid
ES cells [11], haploid ES cells [12,13] and adult germ cells [14,15],
and established procedures for gene transfer in vitro [16,17,18,19]
and in vivo [17,19,20], positive-negative selection (PNS) to enrich
for HR-mediated GT in ES cells [16], and chimera formation
[21].
In order to fully develop the GT technology in medaka, we
chose the p53 gene as a model. p53 is best known as the ‘‘guardian
of the genome’’ and tumor suppressor, as p53 mutations occur in
50% of human cancers [22]. p53 is highly conserved across animal
phyla, as its mutation increases the incidence of tumor formation
in mouse [22] and fish [23,24]. In mice, p53 is involved in several
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other important processes such as senescence and ageing [25]. p53
has been targeted by HR in ES cells of mouse [26] and rat [5].
Previously, we have shown the lack of ultraviolet-light inducibility
of the medaka p53 gene [27], and reported a first attempt toward
the development of GT in medaka ES cells, in which p53 gene was
cloned for the construction of GT vector pGTp53 [28]. In this
work, the genuine GT event was not described, thus parameters
for PNS and GT efficiency remained speculative. We made use of
the pGTp53 vector [28], to continue the effort towards the
establishment of GT technology in fish ES cells. pGTp53 was
devised to disrupt the medaka p53 by HR on the basis of PNS to
allow for enrichment for HR events [29].
This study was aimed at continuing our effort for improving
procedures and efficiency for HR-mediated true p53 GT in
medaka ES cell lines. We show the effectiveness of PNS procedure
in enrichment for the HR event and a high efficiency of GT in
medaka ES cells. More importantly, we demonstrate the retention
of pluripotency of medaka ES cells after long-term drug selection
and targeted p53 disruption.
Results
Gene Transfer and Selection Strategy
For HR-mediated GT experiments, we made use of the GT
vector pGTp53 (Figure 1A) that has been described previously
[28]. Gene transfer of linearized pGTp53 vector into medaka ES
cells was performed by using the GeneJuice reagent (Novagen)
[14,16,18] in 6-well plates. Each well was considered as a pool for
screening of HR-events after gene transfer. Upon HR, the neo
would be co-integrated, while the tk would be recombined away,
with the homologous recombinant being resistant to G418 and
gancyclovir (Gc) owing to the expression of neo and the absence of
tk. Upon random integration (RI), both the neo and tk would be co-
integrated, with random integrants being resistant to G418 but
sensitive to Gc owing to the expression of both neo and tk.
Therefore, the PNS by using G418 and Gc is predicted to enrich
for HR events by eliminating RI events via their sensitivity to Gc
and non-transgenic cells via their sensitivity to G418 (Figure 1B
and C).
High HR Activity in different Medaka ES Cell Lines
There are three medaka ES cell lines, namely MES1-3 [11]. We
first determined whether they possessed reasonable HR activity as
a precondition for GT. To this end, the three cell lines were
transfected in 12-well plates with pGTp53 and the putative HR
event was detected at 5 days post transfection (dpt), by PCR
analysis using primers specific to the targeted p53 locus (Figure 1A).
This led to the detection of a GT-specific PCR product in all of the
six batches of pGTp53-transfected ES cells but not in mock-
transfected cells (Figure S1). PNS by using G418 (500 mg/ml) plus
Gc (5 mM) increased the yield of the GT-specific PCR product.
Importantly, a single round of PCR produced an easily detectable
band in MES1 and MES2 but a faint band in MES3 (Figure S1).
The band for the targeted allele became more intense after a 2nd
round of PCR. Therefore, the three ES cells lines possess high but
different levels of cellular HR activity, and MES1 was chosen for
subsequent experiments because of its high HR activity and
documented ability for chimera formation [21,30] and retention of
pluripotency after gene transfer and long-term drug selection [16].
Efficient p53 Gene Targeting
Compared to RI, HR is a rare event even in mouse ES cells [1].
Previously, we have shown the effectiveness of PNS in model
systems of fish cell culture [28,29]. We wanted to determine the
efficiency of PNS for enrichment for the HR event in medaka ES
cells. To this, 106 transfectants were seeded in 10-cm dish and
grown in the presence of G418 alone or together with Gc, and
colony formation was examined after 23–28 days of culture. In
a typical experiment, selection with G418 alone produced
100,300 colonies per dish, while the number of colonies
decreased to 5–25 per dish upon PNS (Figure 1B and C). A
statistical analysis of three independent experiments led to an
enrichment factor of 12.061.5 for PNS in pGTp53-transfected
MES1 cells (Figure 1D), demonstrating the effectiveness of PNS
for enriching for putative homologous recombinants in medaka ES
cells.
We utilized four procedures to identify genuine homologous
recombinants. A PCR-based genotyping procedure was first used
to screen for the targeted p53 locus, which was amenable for PCR
amplification by using an external primer and neo primer
(Figure 1A). From two batches of experiments, 39 colonies were
successfully transferred and expanded, 19 (48.7%) were positive
for PCR-genotyping (Figure 1E and Table S2 in File S1). When 11
of the PCR-positive colonies were then subjected to Southern blot
analysis, 6 (54.5%) turned out to contain a 9.2-kb band and an 8-
kb band without any visible additional bands, whereas normal
MES1 cells has only the 8-kb band (Figure 1F and Table S2 in File
S1). The 8-kb and 9.2-kb bands conformed to the predicted sizes
of genomic EcoR I-digests for the wildtype allele (7988 bp) and
targeted allele (9253 bp; Figure 1A; for detail refer to File S2). The
targeted allele remained unchanged during $20 passages for
expansion into individual clones (Figure 1G). Fluorescent in situ
hybridization in one of the 6 clones (clone #22) demonstrated the
presence of a single neo signal in the cells at different cell cycle
phases (Figure S2). Sequencing revealed the predicted junction
sequence for the targeted p53 allele (Figure S3). Taken together,
p53 GT has efficiently occurred without detectable RI events and
the targeted p53 allele is as stable as the wildtype allele during
clonal expansion.
Retention of Pluripotency in vitro
To determine whether the pluripotency was compromised by
drug selection and p53 GT, normal MES1 and its p53-targeted
counterparts including clone#22 were analyzed for differentiation
potential in vitro and chimera competence in vivo. Under the
conditions for undifferentiated growth, clone #22 exhibited the
ES-cell phenotype such as a small size and round shape similar to
that of MES1 (Figure 2A and B), and high alkaline phosphatase
activity (Figure 2C), a general marker of fish stem cells
[11,12,14,17]. Moreover, all the six p53-targeted clones examined,
like normal MES1 cells, did exhibit a high level of expression of 9
pluripotency genes including nanog, oct4 and klf4 (Figure 2D),
which have recently been shown to be associated with an
undifferentiated state of medaka stem cells in culture [12,31]. As
expected, the p53 transcript was found at a reduced level in 4 out
of 6 clones, namely clones 22, 32, 35 and 38, as compared to
normal MES1 cells (Figure 2D), in consistence with heterozygosity
at the p53 locus in these clones.
Under the conditions for differentiation induction [11], p53-
targeted cells were able to differentiate spontaneously into various
specialized cell types including neurons with long and thin
cytoplasmic extensions (Figure 3A). They were capable of induced
differentiation via embryoid body (EB) formation in suspension
culture (Figure 3B), and they lost nanog expression and gained
expression of several differentiation genes including the neuroec-
todermal marker nf200, the mesodermal markers ntl and actinin2 as
well as the endodermal marker sox17 (Figure 3C), as have
previously been shown for normal medaka ES cells [11,12,31,32].
p53 Gene Targeting in Fish ES Cells
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Normal MES1 cells can be directed for differentiation by forced
Mitf (microphthalmia-associated transcription factor) expression
into melanocytes [19,33]. Upon transfection with pXmitf, vector
expressing the Xiphophorus Mitf [19], the parental MES1 and p53-
targeted counterparts produced pigmented melanocytes at similar
efficiencies (Figure 3D and E; Figure S4). Taken together, medaka
Figure 1. p53 gene targeting in MES1. (A) Targeting vector pGTp53. gt, gene-targeted; wt, wildtype; filled box, translated exon; open box,
untranslated exon; thin line between boxes, intron; thick line, region included in pGTp53; neo, STneo cassette; tk, STk cassette; E, EcoR I site.
Arrowheads depict the position and extension direction of primers (in1 and in2, p53 primers whose sequences are absent in pGTp53 and the targeted
locus; ex, external primer; neo, neo primer). Probes and EcoR I-digests of predicted sizes for Southern analysis are indicated. (B and C) Colony
formation. Colonies formed from pGTp53-transfected MES1 cells in the presence of G418 alone (B) and G418 plus Gc (C) were Giemsa-stained at day
23 of clonal growth. (D) PNS enrichment factor. (E) PCR detection of the GT event. Genomic DNA was isolated from 39 PNS-resistant colonies and
subjected to PCR detection by using primers (arrows; for positions see Figure 1A) specific to the targeted (gt) and wildtype (wt) locus. Numbers above
lanes, PNS-resistant colonies. Positive colonies are shown in bold. (F) Southern analysis of representative colonies. (G) Southern analysis of
representative clones from colonies after $20 passages of propagation.
doi:10.1371/journal.pone.0059400.g001
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ES cells after long-term drug selection and p53 GT retain the stem
cell phenotype and pluripotency for spontaneous, induced and
directed differentiation in vitro.
Retention of Pluripotency in vivo
We have previously shown that MES1 cells after stable gene
transfer and drug selection were able to give rise to 100% chimera
formation and that these donor cells contributed to a wide variety
of tissues/organs during chimeric embryogenesis [12,16,21,30,34].
In order to test whether this property was retained after long-term
drug selection plus p53 GT, one of p53-targeted clones, clone#22,
was genetically labeled with GFP via transfection by pCVpf and
introduced into host blastulae. This generated 100% GFP-positive
chimeras in which the GFP-positive donor cells were distributed to
many compartments during early embryogenesis and to many
tissues/organs at advanced stages (Figure 4A and B). Upon co-
transplantation into blastula hosts, GFP-labeled cells of clone #22
were not different from RFP-labeled normal MES1 cells in
distribution and differentiation in developing chimeric embryos
(Figure 4C-E; Figure S5). Thus, p53-targeted ES cells have
retained pluripotency in vivo.
Recently, we have shown that interordinal chimera formation
between medaka and zebrafish is a powerful tool for analyzing
stem cell differentiation [35]. Specifically, interordinal chimera
formation allows for a molecular analysis of ES cell differentiation
along multiple cell lineages through RT-PCR assays by using
primers that are specific to donor cell cDNAs. We adopted this
approach. p53-targeted cells (clone #22) exhibited wide distribu-
tion to major compartments of 1-day-old zebrafish host embryos
(Figure 5A and B). A similar observation was made also on
parental MES1 cells (Figure 5C and D). The detection of medaka
three germ layers (ectodermal, eed and gfap; mesodermal, myf5;
endomermal, sox17) and neural crest (mitf1) markers in zebrafish
host by RT-PCR revealed that in vivo differentiation potential of
both parental MES1 cells and p53-targeted ES cells (#22 clone)
(Figure 5E). Co-transplantation experiments revealed that MES1
and #22 cells had highly overlapping distribution (Figure 5F–J).
Hence, we conclude that, as in mouse ES cells, drug selection and
GT do not compromise the pluripotency of medaka ES cells.
Discussion
Medaka and zebrafish are excellent twin model organisms for
analyzing vertebrate development [10], studying stem cell biology
[11,12,14,17,30,36,37] and more importantly, for developing the
ES cell technology [16,28,29]. As a key step towards the full
development of the ES cell technology in this organism, the
present work has addressed five important issues. First, we show
that all the three medaka ES cell lines possess a significant level of
cellular HR activity, allowing for easy detection of HR events as
Figure 2. Pluripotency in vitro. (A) Phenotype of parental MES1 cells. (B) Phenotype of p53-targeted clone#22. (C) Alkaline staining of clone#22.
(D) Pluripotency gene expression profile in five p53-targeted MES1 clones. neg, negative control without cDNA template. actin was used as a loading
control. Blastula embryos and parental MES1 were used as positive controls. Scale bars, 25 mm.
doi:10.1371/journal.pone.0059400.g002
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Figure 3. Differentiation in vitro. (A) Spontaneous differentiation of p53-targeted MES1 clone #22 into neurons. (B) Embryoid body (EB)
formation of MES1 (left) and clone #22 (right). (C) Expression of differentiation genes upon induced differentiation by EB formation. nf200,
neurofilament 200; ntl, no tail; actn2, actinin 2. (D and E) Directed differentiation into melanocytes (asterisks) by forced Mitf expression from pXmitf.
Scale bars, 50 mm.
doi:10.1371/journal.pone.0059400.g003
Figure 4. Pluripotency in vivo. Embryos at the midblastula stage were transplanted with ES cells and photographed at day 3 (A) and 7 post
fertilization (B–E). (A and B) Merged micrographs of chimeras, showing GFP-labeled ES cells of p53-targeted clone #22 in many compartments and
organ systems including the eye (ey), head (hd), heart (ht), gall bladder (gb) and pectoral fin (pf). od, oil droplet; ys, yolk sac. (C–E) Co-distribution of
parental MES1 and p53-targeted clone #22 in the developing chimera at day 7 post fertilization. Following genetic labeling by plasmid transfection,
parental MES1 (red) and clone #22 (green) were mixed at 1:1 ratio and transplanted at approximately 200 cells per blastula. (D and E) Larger
magnification of the posterior trunk framed in (C) and anterior end. The embryo is 1 mm in diameter.
doi:10.1371/journal.pone.0059400.g004
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early as just a few days of culture post transfection even in the
absence of enrichment by drug selection. Second, we reveal that
PNS is effective in enriching for HR events, producing a 12-fold
enhancement factor, which is within the range of 2,100 folds
reported for mouse ES cells. Third, we demonstrate that p53 GT
in medaka ES cells occurs at a frequency 26% under PNS
Figure 5. Chimeric assay of pluripotency in vivo. Zebrafish blastulae were used as the host for transplantation of MES1 (red), #22 (green) or
both and analyzed at 1 dpf by microscopy and RT-PCR. (A and B) Chimeras by transplantation of #22 cells on fluorescent micrograph (A) and merge
between fluorescent and brightfield optics (B). (C and D) Chimeras by transplantation of MES1 cells on fluorescent micrograph (C) and merge
between fluorescent and brightfield optics (D). (E) RT-PCR analysis of gene expression. MES1, #22, 1-day-old embryos of medaka and zebrafish were
used for comparison. Primers used were specific to medaka cDNAs, except for b-actin primers that amplify the b-actin cDNA of both medaka and
zebrafish. (F–J) Chimera by cotransplantation of MES1 and #22 cells on brightfield (F), brightfield-fluorescent merge (G), GFP fluorescence (H), RFP
fluorescence (I) and merge between GFP and RFP optics (J). Scale bars, 200 mm.
doi:10.1371/journal.pone.0059400.g005
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condition, a proficiency that is 13 times higher than a ,2%
efficiency for p53 GT in ES cells of mouse [38] and rat [5]. With
this high proficiency, it is possible to obtain a sufficient number of
cell clones with a targeted locus from a few dozens of PNS-
resistant colonies in a single transfection experiment. Fourth, our
finding that all clones examined in this study are stable in growth
and genetic stability indicate that a single copy of wildtype p53
gene is sufficient for ES cell maintenance, in accordance with the
observation that p53 heterozygosity is sufficient to support ES cell
maintenance in mouse [26] and rat [5] as well as normal
development in medaka [24]. Finally and most importantly, we
have provided compelling evidence that p53-targeted medaka ES
cells retain pluripotency in vitro and in vivo, thus establishing
medaka as first lower vertebrate organism to fully develop the
HR-based GT technology.
Site-specific gene alterations can also be achieved by using
engineered sequence-specific endonucleases such as ZFNs and
TALENs. The ZFN or TALEN approach can introduce only
minor additions or deletions in an unpredictable manner and are
thus limited to gene disruption. Furthermore, this approach may
also produce off-target alterations that are difficult to predict and
detect. In contrast, HR-based GT generates precisely designed
gene replacement, which allows for both gene disruption and
correction and essentially alleviate the off-target concern. There-
fore, the HR-based GT in ES cells followed by germline
transmission still represents the approach of choice to engineer
the genome at the best precision [1].
This study has focused on, successes in, HR-based GT in
medaka ES cells by using p53 as a model. This success
corroborates and extends our previous effort with the same HR
vector in MES1 cells [28], and extends the early study by
demonstrating the first true success in bona fide GT in MES1 cells
and the retention of pluripotency in vitro and in vivo. The next key
step is to achieve germline transmission for whole animal
production, as has been done in mouse [1] and rat [5]. In
zebrafish, blastula cells after short-term culture can form germline
chimeras [39]. In medaka, germline chimera formation from ES
cell lines has not yet been described, in spite of continuous efforts
[21,30,34]. Our previous study has indicated that medaka germ
cell formation appears to be controlled by a cell-autonomous
mechanism [40], raising the possibility that the medaka germline is
inaccessible to colonization by cultured ES cells. Recently, we
have generated medaka haploid ES cells capable of germline
transmission by semicloning [12]. It is anticipated that GT in these
haploid ES cells in combination with semicloning will provide an
alternative approach for the production of knockout animals in
this organism. The procedures and efficiencies established in
present study will offer valuable information for GT in medaka
haploid ES cells.
Materials and Methods
Fish and Reagents
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Advisory Committee for
Laboratory Animal Research in Singapore and approved by this
committee (Permit Number: 27/09). Medaka strain af was
maintained under an artificial photoperiod of 14-h light to 10-h
darkness at 26,28uC as described [19,21]. Embryos were
maintained at 26,28uC and staged as described [41]. Unless
otherwise indicated, chemicals were purchased from Sigma,
enzymes and PCR reagents were from Promega and TaKaRa.
Cell Culture
Maintenance of the medaka ES cell lines MES1-3 were
maintained at 28uC under feeder-free culture conditions on
gelatin-coated substrata in culture medium ESM4 and staining for
alkaline phosphatase activity were performed as previously
described [11,42].
Plasmids
The GT plasmid pGTp53 targeting the medaka p53 gene was
described [28]. Vectors pCVpf and pCVpr were used for drug
selection and GFP or RFP expression for cell labeling [19].
Plasmid DNA was prepared by using the Qiagen Maxi and Midi
preparation kits (Qiagen, Germany).
Cell Transfection and Colony Isolation
Cell transfection with plasmid DNA by using the GeneJuice
reagent (Novagen) and drug selection were performed as described
[14,16,18]. Briefly, cells seeded in 6-well plates were incubated
with linearized pGTp53 vector in a serum-free medium for 6 h.
After medium change to ESM4, the cells were grown for 3 days
and trypsinized into single cells. A quarter of the cells were
collected for the PCR analysis (see below), and the remainder were
subcultured into 10-cm gelatin-coated Petri dishes (plating) for
PNS by using G418 (Gibco) at 500 mg/mL and Gc (Cymevan,
Syntex Arzneimittel GmbH, Switzerland) at 5 mM.
After plating, pGTp53-transfected MES1 cells were grown
under drug selection for up to 28 days. Dishes with #200 colonies
were subjected to manual colony isolation. After transferring the
PNS-resistant colonies into 96-well plate, a monolayer formed
during 10–14 days of culture, with medium being changed every
3–5 days. After 7–12 days of culture, colonies were split into three
96-well plates. Two plates were used for by Southern (plate A) and
PCR (plate B) analyses (see below), respectively, where the third
was used as master plate (plate C) for cell propagation.
Micro-extraction of DNA. DNA samples from 96-well plates
were isolated by using the micro-extraction procedure [43] with
minor modifications. Briefly, the DNA was extracted by adding
cell lysis buffer (10 mM Tris-HCl, pH7.5, 10 mM EDTA, 10 mM
NaCl, 0.5% sarcosyl, and 500 mg/mL proteinase K), incubation at
55uC for 12–16 h and precipitation by NaCl and cold ethanol
(1.5 mL of 5 M NaCl to 100 mL of absolute ethanol). After the
70% ethanol wash, 50 mL of autoclaved Milli-Q water was added
to each well. DNA was dissolved and restored at 4uC until use.
PCR
PCR-based genotyping was conducted from pooled cell
populations or single PNS-resistant colonies by two sequential
rounds of PCR. The first round of PCR was run for 35 cycles
(94uC for 30 s, 60uC for 30 s and 72uC for 90 s) in a 25-mL
volume containing 2 ml of DNA prepared above. The second
round of PCR was similarly run for 30 cycles in a 25-mL volume
containing 2 mL of the 10 times diluted 1st round PCR product.
PCR primers are listed in Table S1 in File S1. The PCR screening
of PNS-resistant clones was performed using DNA samples
prepared from 96-well plate. PCR products were separated on
a 1.0% agarose gel and documented with a bio-imaging system
(Synoptics, Cambridge).
For RT-PCR, total RNA was isolated by using the Trizol
Reagent (Invitrogen). Synthesis of cDNA templates was primed
with oligo (dT)18 by using M-MLV transcriptase (Invitrogen). The
cDNA reaction was diluted with water to 10 ng/mL. RT-PCR was
run as previously described [12,14]. PCR primers are listed in
Table S1 in File S1.
p53 Gene Targeting in Fish ES Cells
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Southern Analysis
DNA extraction was similarly done as described above but to
a larger scale. Ten mg of genomic DNA was digested with EcoR I
enzyme at 37uC for 30–40 h. The digested DNA fragments were
separated on a 0.8% TBE agarose gel by electrophoresis at 30 V
for 16 h at 4uC. After photograph and de-purination treatment
with 0.2 M HCl for 10 min, the DNA was transferred to Hybond
N+ nylon membrane (GE healthcare, USA) for 5 h by alkaline
buffer (0.5 M NaOH, 1.5 M NaCl). Following transfer, the
membrane was pre-hybridized with DIG-Easy solution (Roche)
containing 100 mg/ml of pre-boiled calf thymus DNA fragments
(#2 kb in size) at 42uC of 12–16 h. The probe was labeled with
digoxygenin (a mixture of 100,1000-bp fragments synthesized
from a 1.5-kb 59-external sequence; for detail see Table S1 in File
S1) by random-primed DNA synthesis (Roche), then hybridized to
the membrane at 42uC in DIG-easy solution containing 100 mg/
ml of calf thymus DNA for 40 h. Non-specific binding was
removed by washing in 2 6 SSC/0.5% SDS (twice), and 0.1 6
SSC/0.5% SDS at 65uC for 10 min each. Followed by an
overnight incubation at 4uC with a 1:5000 diluted anti-DIG-POD
antibody (Roche) in 1 6 maleic acid solution containing 1.5%
blocking reagent (Roche), the hybridization signal was visualized
after chemiluminescent reaction by using the ECL reagent
(Amersham Biosciences) and developed by exposure for 8 h to
films (Kodak).
Sequencing
DNA fragments were subcloned into pGEM-T easy vector
(Promega) and sequenced on an ABI3100 automatic sequencer
(Applied Biosystems). Sequence analyses were performed by using
the Vector NTI package (Invitrogen).
Chromosome Preparation and Fluorescent in situ
Hybridization
Chromosome samples were prepared essentially as described
[11,12]. To determine the integrated transgene neo in the genome,
the p53GT22 clone was subjected to fluorescent in situ hybridiza-
tion (FISH) as described [18]. The DNA fragment containing the
STneo was obtained from pGTp53, labeled with biotinylated
dUTP by using the Biotin-High Prime kit (Roche, Mannheim) and
used as a probe for FISH on nuclei and metaphases. Chromo-
somes were counterstained with propidium iodide (Sigma, USA).
Induced Cell Differentiation
MES1 cells and p53-targeted cell clones were subjected to EB
formation in suspension culture in the presence of all-trans retinoic
acid (RA; 10 mM, final) for induced differentiation [11,12,13]. Cell
differentiation was monitored by phenotype and studied by RT-
PCR analyses of expression of pluripotency and lineage-specific
genes [12,31].
Cell Labeling
Cells were stably labeled by transfection with pCVpf or pCVpr
followed by puromycin selection (1 mg/ml) and clonal expansion
of GFP- or RFP-expressing colonies [16,18]. Alternatively, cells
were transiently labeled by staining with fluorescent dyes PKH26
(red; Sigma) or PKH67 (green; Sigma) for 3 min at final
concentration of 2 mM in Diluent C, followed by rinses in PBS
as described [35].
Chimera Formation
Labeled MES1 cells and p53-targeted cell clones were
transplanted alone or together into dechorionated blastula
embryos of strain af and donor cells were monitored regularly as
described [18,21,30]. Transplantation of medaka ES cells into
zebrafish blastulae for interordinal chimeric formation was
performed as described [35].
Microscopy
Observation and photography on Leica MZFIII stereo micro-
scope, Zeiss Axiovert invert and Axiovert upright microscopes
were as described [12,20,21,32,44].
Statistics
Statistical analyses were calculated by using Origin 6.1 software.
Data consolidated were presented as mean 6 SD and p values
were calculated by using non-parametric student’s t-test.
Supporting Information
Figure S1 Detection of HR activity of medaka ES cell
lines. High HR activity of medaka ES cell lines. ES cell lines
MES1 to 3 were transfected with pGTp53 (+) or pBluescript as
mock transfection control (-), and subjected to PCR detection
following 5 days of growth in the absence of drug or 14 days of
growth under PNS.
(TIF)
Figure S2 FISH detection of p53 gene targeting. (A-C)
Metaphases. (D-F) Nuclei. The FISH signal is green (arrows). Cells
of clone #22 were hybridized with the fluorescein-labeled neo
probe (green; probe 2 in Figure 1A) and stained for nuclei with
propidium iodide (PI, red). The neo signal is highlighted by arrows.
Scale bars, 10 mm.
(TIF)
Figure S3 Junction sequence of targeted p53 locus. GT
vector and targeted locus. neo, cassette expressing neomycin
aminoglycoside phosphotransferase for resistance to G418. Paired
arrows depict the position of PCR primers on the targeted p53
locus. Sequences of five p53-targeted ES clones. The p53 sequence
included in the GT vector is shown in black. Shown here are only
junction sequences. Shown in bold are ATG codon, polyA signal
and stop codon introduced immediately downstream of ATG.
(TIF)
Figure S4 Efficiency of Mitf-directed melanocyte differ-
entiation. MES1 and p53-targeted clones were transfected with
pXmitf and pCVpf, the former expressing the Xiphophorus
melanocyte-specific isoform of microphthalmia-associated tran-
scription factor (mitf-M) and latter expressing pf, a fusion between
the puromycin acetyltransferase and GFP. Following co-trans-
fection, cells were pulse-selected with puromycin for 2 days to
enrich for transgenic cells. At day 5 post transfection, cell counting
was done on merged micrographs of living cells, and percent
values of melanocytes and GFP-positive cells were derived by
a comparison to the total number of $500 cells for MES1 and
clones each.
(TIF)
Figure S5 Distribution of MES1 and p53-targeted clone
22 in developing chimeras. Following genetic labeling by
plasmid transfection, parental MES1 (red) clone #22 (green) were
mixed at 1:1 ratio and transplanted at ,200 cells per blastula. In
total, 54 chimeras were daily scored from day 3 to 7 post
fertilization.
(TIF)
File S1 Table S1 & S2.
(DOC)
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